0

Journal Articles

in Percutaneous Coronary Intervention
 1-20 of 129 Articles
JAMA | 
Medical News and Perspectives |  May 01, 2013
Study Ignites Debate on New Anticoagulant
Mike Mitka, MSJ
JAMA. 2013;309(17):1763-1764. doi:10.1001/jama.2013.3857.
JAMA | 
Original Contribution |  March 13, 2013
Association Between Bleeding Events and In-hospital Mortality After Percutaneous Coronary Intervention
Adnan K. Chhatriwalla, MD; Amit P. Amin, MD; Kevin F. Kennedy, MS; et al.
JAMA. 2013;309(10):1022-1029. doi:10.1001/jama.2013.1556.
INCLUDES: , Supplemental Content
JAMA | 
Medical News and Perspectives |  January 02, 2013
CABG Again Outshines Stenting for Some Patients With Coronary Artery Blockage
Mike Mitka, MSJ
JAMA. 2013;309(1):17-18. doi:10.1001/jama.2012.97092.
JAMA | 
Review |  December 19, 2012
Association of Clopidogrel Pretreatment With Mortality, Cardiovascular Events, and Major Bleeding Among Patients Undergoing Percutaneous Coronary Intervention:  A Systematic Review and Meta-analysis
Anne Bellemain-Appaix, MD; Stephen A. O’Connor, MD; Johanne Silvain, MD, PhD; et al.
JAMA. 2012;308(23):2507-2516. doi:10.1001/jama.2012.50788.
INCLUDES: CME , Supplemental Content
JAMA | 
Preliminary Communication |  December 12, 2012
Effect of the Use and Timing of Bone Marrow Mononuclear Cell Delivery on Left Ventricular Function After Acute Myocardial Infarction:  The TIME Randomized Trial
Jay H. Traverse, MD; Timothy D. Henry, MD; Carl J. Pepine, MD; et al.
JAMA. 2012;308(22):2380-2389. doi:10.1001/jama.2012.28726.
JAMA | 
Editorial |  November 07, 2012 FREE
Measured Drug Effect and Cardiovascular Outcomes in Patients Receiving Platelet P2Y12 Receptor Antagonists:  Clarifying the Time and Place for Intensive Inhibition
Matthew J. Price, MD
JAMA. 2012;308(17):1806-1808. doi:10.1001/jama.2012.34011.
JAMA | 
Editorial |  October 10, 2012
Public Reporting of PCI Outcomes and Quality of Care:  One Step Forward and New Questions Raised
Mauro Moscucci, MD, MBA
JAMA. 2012;308(14):1478-1479. doi:10.1001/jama.2012.13389.
JAMA | 
Original Contribution |  October 10, 2012 FREE
Association of Public Reporting for Percutaneous Coronary Intervention With Utilization and Outcomes Among Medicare Beneficiaries With Acute Myocardial Infarction
Karen E. Joynt, MD, MPH; Daniel M. Blumenthal, MD, MBA; E. John Orav, PhD; et al.
JAMA. 2012;308(14):1460-1468. doi:10.1001/jama.2012.12922.
INCLUDES: , Supplemental Content
JAMA Surgery | 
Original Article |  October 01, 2012
Initial Experience With Hyperthermic Intraperitoneal Chemotherapy
Olivier Turrini, MD; Eric Lambaudie, MD; Marion Faucher, MD; et al.
Arch Surg. 2012;147(10):919-923. doi:10.1001/archsurg.2012.988.
JAMA Internal Medicine | 
Invited Commentary |  August 13, 2012
How Drug-Eluting Stents Illustrate Our Health System's Flawed Relationship With Technology:  Comment on “Use of Drug-Eluting Stents as a Function of Predicted Benefit”
Peter W. Groeneveld, MD, MS
Arch Intern Med. 2012;172(15):1152-1153. doi:10.1001/archinternmed.2012.2724.
JAMA Internal Medicine | 
Original Investigation |  August 13, 2012
Use of Drug-Eluting Stents as a Function of Predicted Benefit:  Clinical and Economic Implications of Current Practice
Amit P. Amin, MD, MSc; John A. Spertus, MD, MPH; David J. Cohen, MD, MSc; et al.
Arch Intern Med. 2012;172(15):1145-1152. doi:10.1001/archinternmed.2012.3093.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Editor's Correspondence |  July 09, 2012
Percutaneous Coronary Intervention for Stable Coronary Artery Disease: The Debate Continues
Elvis A. Peter, MD; Nuri I. Akkus, MD; Jai Varma, MD, FSCAI
Arch Intern Med. 2012;172(13):1043-1044. doi:10.1001/archinternmed.2012.1753.
JAMA Internal Medicine | 
Invited Commentary |  June 11, 2012
Routine Periodic Stress Testing in Asymptomatic Patients Following Coronary Revascularization: Is It Worth the Effort?:  Comment on “Exercise Testing in Asymptomatic Patients After Revascularization”
Mark J. Eisenberg, MD, MPH
Arch Intern Med. 2012;172(11):861-863. doi:10.1001/archinternmed.2012.1910.
JAMA Internal Medicine | 
Original Investigation |  June 11, 2012
Exercise Testing in Asymptomatic Patients After Revascularization:  Are Outcomes Altered?
Serge C. Harb, MD; Thomas Cook, MPH, PhD; Wael A. Jaber, MD; et al.
Arch Intern Med. 2012;172(11):854-861. doi:10.1001/archinternmed.2012.1355.
JAMA Internal Medicine | 
Invited Commentary |  June 11, 2012
Activating Primary Percutaneous Coronary Intervention for STEMI That Is Not: The Collateral Damage of Improving Door-to-Balloon Time:  Comment on “Prevalence and Factors Associated With False-Positive ST-Segment Elevation Myocardial Infarction Diagnoses at Primary Percutaneous Coronary Intervention–Capable Centers”
Fouad Bachour, MD; Richard Asinger, MD
Arch Intern Med. 2012;172(11):871. doi:10.1001/archinternmed.2012.1117.
JAMA Internal Medicine | 
Original Investigation |  June 11, 2012
Prevalence and Factors Associated With False-Positive ST-Segment Elevation Myocardial Infarction Diagnoses at Primary Percutaneous Coronary Intervention–Capable Centers:  A Report From the Activate-SF Registry
James M. McCabe, MD; Ehrin J. Armstrong, MD, MSc; Ameya Kulkarni, MD; et al.
Arch Intern Med. 2012;172(11):864-871. doi:10.1001/archinternmed.2012.945.
JAMA Internal Medicine | 
Invited Commentary |  March 26, 2012
Interpreting Biomarkers During Percutaneous Coronary Intervention: The Need to Reevaluate Our Approach:  Comment on “Troponin Criteria for Myocardial Infarction After Percutaneous Coronary Intervention”
Joseph S. Alpert, MD; Allan S. Jaffe, MD
Arch Intern Med. 2012;172(6):508-509. doi:10.1001/archinternmed.2011.2284.
JAMA Internal Medicine | 
Invited Commentary |  February 27, 2012
Mounting Evidence for Lack of PCI Benefit in Stable Ischemic Heart Disease:What More Will It Take to Turn the Tide of Treatment?:  Comment on "Initial Coronary Stent Implantation With Medical Therapy vs Medical Therapy Alone for Stable Coronary Artery Disease"
William E. Boden, MD
Arch Intern Med. 2012;172(4):319-321. doi:10.1001/archinternmed.2011.2321.
JAMA Internal Medicine | 
Original Investigation |  February 27, 2012 FREE
A Randomized Controlled Trial of Positive-Affect Induction to Promote Physical Activity After Percutaneous Coronary Intervention
Janey C. Peterson, EdD, MS, RN; Mary E. Charlson, MD; Zachary Hoffman, BS; et al.
Arch Intern Med. 2012;172(4):329-336. doi:10.1001/archinternmed.2011.1311.
JAMA Internal Medicine | 
Editorial |  January 23, 2012
Reconsidering Transfer for Percutaneous Coronary Intervention Strategy:  Time Is of the Essence
Rita F. Redberg, MD, MSc
Arch Intern Med. 2012;172(2):98-99. doi:10.1001/archinternmed.2011.566.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
Medical News and Perspectives  |  May 01, 2013
Study Ignites Debate on New Anticoagulant
Mike Mitka, MSJ
JAMA
Original Contribution  |  March 13, 2013
Association Between Bleeding Events and In-hospital Mortality After Percutaneous Coronary Intervention
Adnan K. Chhatriwalla, MD; Amit P. Amin, MD; Kevin F. Kennedy, MS; et al.
JAMA
Medical News and Perspectives  |  January 2, 2013
CABG Again Outshines Stenting for Some Patients With Coronary Artery Blockage
Mike Mitka, MSJ
JAMA
Review  |  December 19, 2012
Association of Clopidogrel Pretreatment With Mortality, Cardiovascular Events, and Major Bleeding Among Patients Undergoing Percutaneous Coronary Intervention:  A Systematic Review and Meta-analysis
Anne Bellemain-Appaix, MD; Stephen A. O’Connor, MD; Johanne Silvain, MD, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems